

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb10392</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>Interleukin 10 and Transforming Growth Factor Beta Polymorphisms as Risk Factors for Kawasaki Disease: A Case-Control Study and Meta-Analysis</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Rahmani</surname><given-names>Farzaneh</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Ziaee</surname><given-names>Vahid</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Assari</surname><given-names>Raheleh</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Sadr</surname><given-names>Maryam</given-names></name></contrib><aff>Department of Biology, Research Center for Applied Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Rezaei</surname><given-names>Arezou</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Sadr</surname><given-names>Zeinab</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Raeeskarami</surname><given-names>Seyed Reza</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Moradinejad</surname><given-names>Mohammad Hassan</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Aghighi</surname><given-names>Yahya</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Rezaei</surname><given-names>Nima</given-names></name></contrib><aff>Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran      , Tehran, Iran</aff></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>11</volume>
      <issue>4</issue>
      <fpage>325</fpage>
      <lpage>333</lpage>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>8</month>
          <year>2018</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>10</month>
          <year>2018</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p&gt;Background: Alteration in serum expression of Transforming Growth Factor-beta (TGF-&amp;beta;) and IL-10 have been suggested to play a role in the pathogenesis of Kawa-saki Disease (KD). Inconsistent reports exist on the association of IL-10 polymorphisms with KD susceptibility and Coronary Artery Aneurysms (CAA).&amp;nbsp;&lt;br /&gt;
Methods: A number of 110 paediatric patients with KD and 140 healthy individuals were recruited to investigate the frequency of Single Nucleotide Polymorphisms (SNPs) of TGF-&amp;beta; C/T at codon 10 (rs1982073), C/G at codon 25 (rs1800471) and IL-10 A/G at -1082 (rs1800896), C/T at -819 (rs1800871) and A/C at -592 (rs1800872) and their respective genotype and haplotypes. A comprehensive search was performed in MEDLINE and SCOPUS using the keywords of interleukin 10, transforming growth factor beta, and Kawasaki disease. Moreover, previous studies investigating the TGF-&amp;beta; and IL-10 polymorphisms in KD were evaluated. Review Manager Version 5.1 Software was used to perform meta-analysis.&lt;br /&gt;
Results: There was no significant association between allelic or genotypic variants in the mentioned polymorphisms in TGF-&amp;beta; or IL-10 with KD or CAA. The only significant haplotypic variant was TC variant at codon 10, and 25 of TGF-&amp;beta; polymorphisms were associated with higher risk of KD. Meta-analysis of a total number of 770 patients vs. 1471 healthy controls showed no difference in the frequency of any of the IL-10 genetic variants in KD patients, regardless of the presence of CAA.&lt;br /&gt;
Conclusion: Polymorphisms of TGF-&amp;beta; or IL-10 are not associated with additional risk for KD in Iranian population. IL-10 polymorphisms at -1082, -819 and -592 positions are not associated with KD, nor do they predict coronary artery aneurysm formation.&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
